Candel Therapeutics, Inc. (CADL) financial statements (2022 and earlier)

Company profile

Business Address 117 KENDRICK STREET
NEEDHAM, MA 02494
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments82,642
Cash and cash equivalents82,642
Other undisclosed current assets2,303
Total current assets:84,945
Noncurrent Assets
Property, plant and equipment3,836
Other noncurrent assets424
Total noncurrent assets:4,260
TOTAL ASSETS:89,205
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,028
Accounts payable1,590
Accrued liabilities3,438
Other liabilities334
Total current liabilities:5,362
Noncurrent Liabilities
Liabilities, other than long-term debt894
Deferred rent credit894
Other undisclosed noncurrent liabilities18,812
Total noncurrent liabilities:19,706
Total liabilities:25,068
Stockholders' equity
Stockholders' equity attributable to parent64,137
Common stock286
Additional paid in capital144,146
Accumulated deficit(80,295)
Total stockholders' equity:64,137
TOTAL LIABILITIES AND EQUITY:89,205

Income statement (P&L) ($ in thousands)

12/31/2021
Revenues125
Gross profit:125
Operating expenses(25,851)
Operating loss:(25,726)
Nonoperating expense(10,398)
Net loss available to common stockholders, diluted:(36,124)

Comprehensive Income ($ in thousands)

12/31/2021
Net loss:(36,124)
Comprehensive loss, net of tax, attributable to parent:(36,124)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: